Onco panel, offered by Diatech Pharmacogenetics (Jesi, Italy), has CE-IVD certification and covers 56 genes including usual glioma marker genes such as BRAF, CDKN2A, EGFR, IDH1, IDH2, NOTCH, and TP53 (Marchetti et al., 2021; Eurofins Genomics, 2023). This evidence concerns the gene IDH1 and glioma.